Institutional members access full text with Ovid®

Share this article on:

Pediatric Headache

Hershey, Andrew D. MD, PhD, FAHS

CONTINUUM: Lifelong Learning in Neurology: August 2015 - Volume 21 - Issue 4, Headache - p 1132–1145
doi: 10.1212/CON.0000000000000197
Review Articles

ABSTRACT Purpose of Review: Headache is one of the most common health concerns in children and adolescents, yet remains underrecognized as a disease. A variety of factors, including the unique aspects of childhood headaches, contribute to this underrecognition.

Recent Findings: Improving recognition of childhood and adolescent headaches and using a standardized approach for their evaluation is expected to lead to the appropriate diagnosis and subsequent additional evaluation and management to improve the overall outcome in children and adolescents with headaches. Building on limited studies in children and adolescents and translating adult studies to children can assist in designing a multidisciplinary treatment plan.

Summary: This review focuses on some of the unique aspects of evaluating children and adolescents with headaches; the impact of these headaches on school, home, and family function; determination of disability and influence of comorbid conditions; and development of a treatment plan that incorporates acute, preventive, and biobehavioral management tools.

Address correspondence to Dr Andrew D. Hershey, Cincinnati Children’s Hospital Medical Center, 3333 Burnet Ave, MLC 2015, Cincinnati, OH 45229,

Relationship Disclosure: Dr Hershey serves on the board of directors of the American Headache Society.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Hershey discusses the unlabeled/investigational use of amitriptyline, cyproheptadine, divalproate, and triptans for the treatment of migraines in children.

© 2015 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website